For the first time in two decades, the Federal Government is subsiding a new menopausal hormone therapy.
From the 1st of March, Estrogel Pro (estradiol/progesterone), Estrogel (estradiol), and Prometrium (progesterone) will be available through the Pharmaceutical Benefits Scheme.
More than 100,000 Australian women pay around $650 per year for these treatments. Now, under the PBS, patients will pay up to $31,60 a month.
Menopause is the process that a woman’s body permanently stops the menstrual period, caused by a drop of reproductive hormones. These hormone therapies replace the hormones lost and ease the symptoms that negatively affect the day-to-day life of menopausal women.
